Please use the form below to contact Alnylam Pharmaceuticals and the ILLUMINATE Study Team for more information, and to see if you or someone you care for may qualify for an ILLUMINATE trial.
* Denotes a required field
Alnylam takes your privacy very seriously and will never disclose or share your data without your consent other than for the purposes specified in the Privacy Notice unless required to do so by law. We will use your personal information only for the purposes of informing you about our clinical research studies, or to ask for general information about your condition that may enhance our research program.
With your permission, we may provide your details to an ILLUMINATE study doctor to allow them to contact you about potential study participation.
By providing and submitting your information to Alnylam, you are agreeing with the terms and conditions in our privacy notice. Submission does not oblige you or the person or child with PH1 to participate in our studies, and Alnylam cannot guarantee that you/they will be able to take part in the study.
You can arrange for your information to be deleted from our database at any time by contacting KPI Agency at firstname.lastname@example.org. Please make a note of this email address.
Email: email@example.com Toll-free within the U.S.: 1-877-ALNYLAM
Please note that we are not accepting applications for individuals from your location at this time. For further information about the ILLUMINATE study, Please contact the study sponsor by e-mail at firstname.lastname@example.org.